Calcium and Lenvatinib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium (calcium) and Lenvatinib (lenvatinib). Common drug interactions include pyrexia among females and cardiomyopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Calcium and Lenvatinib. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,203 Calcium users. Check the latest studies of Calcium.

What is Lenvatinib?

Lenvatinib has active ingredients of lenvatinib. eHealthMe is studying from 3,587 Lenvatinib users. Check the latest studies of Lenvatinib.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

59 people who take Calcium and Lenvatinib together, and have interactions are studied.

Calcium and Lenvatinib drug interactions.

What are the common drug interactions of Calcium and Lenvatinib, by gender? *:

female:

Pyrexia (fever)
Renal impairment (severely reduced kidney function)
Dyspnoea (difficult or laboured respiration)
Blood pressure increased
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Abdominal pain
Drug intolerance (drug sensitivity)
Malignant neoplasm progression (cancer tumour came back)
Abdominal pain upper

male:

Cardiomyopathy (weakening of the heart muscle)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
Cholecystitis (infection of gallbladder)
Lymphoedema (localized fluid retention and tissue swelling)
Asthenia (weakness)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Decreased appetite
Dry mouth

What are the common drug interactions of Calcium and Lenvatinib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Dyspnoea (difficult or laboured respiration)
Pyrexia (fever)
Anaemia (lack of blood)
Bile duct stenosis (abnormal narrowing of the common bile duct)
Diarrhoea
Hepatitis acute
Pancreatic duct stenosis (abnormal narrowing of a passage in the pancreatic duct)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Oesophageal perforation (hole in oesophagus)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

60+:

Pyrexia (fever)
Renal impairment (severely reduced kidney function)
Anxiety
Constipation
Heart rate increased
Hypertension (high blood pressure)
Renal failure (kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)
Wheezing (a high-pitched whistling sound made while you breath)
Urinary tract infection

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 18 people, 30.51%
Endometrial Cancer: 9 people, 15.25%
Hepatocellular Carcinoma (liver cancer): 7 people, 11.86%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium and Lenvatinib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously